COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by slagheapon Nov 23, 2015 5:42pm

105 Views

Post# 24317520

RE:RE:RE:RE:RE:Doubled my money!

I realize the financing `poisoned the well` for many investors but I can`t think of a good reason why the valuation will not return to the pre-financing range of $50 - $60 considering that valuation was based on a successful phase 3 drug candidate and the details of the financing were not public knowledge. The financing totally distorted the value of the company and fair value in an open market should be expected.

Bullboard Posts

A Look into the Future of Chronic Pain Management